StemCells, Inc. Faces Lawsuit With Serious Allegations
StemCells, Inc. is one of those stem cell-related biotech companies that we in the field hope will become a big success and help many patients in the future via stem cell technology. There are a lot of...
View ArticleTop 10 questions for stem cell field bouncing around on a Friday morning
What are the most interesting questions for the stem cell field in 2014 right now? What’s on your mind? I’m not going to give this deep thought, but rather just list those questions bouncing around at...
View ArticleStemCells Inc. leadership interview: Pipeline, Financials, IP Conflict with...
StemCells, Inc. is a top biotech company developing stem cell-based therapies. They have a deep pipeline that includes already ongoing trials for a variety of diseases. I invited company leadership to...
View ArticleWhat is the top stem cell biotech of 2014? Take our poll
What is the most exciting, important, promising, all-around awesome stem cell biotech of 2014? Vote and tell us why in the comments.
View ArticleSummaries of WAFSF super stem cell vision talks: Hinton, Tsukamoto, Klassen,...
Recently I was at the World Alliance Forum in San Francisco (WAFSF), a great meeting on stem cells and regenerative medicine. WAFSF had some excellent talks and I saw one session on the use of stem...
View ArticleReview of Biotech/Translational Talks #ISSCR2015: StemCells Inc, Semma,...
By Heather Main The path to the clinic is a slow and arduous activity, frustrating not only to the researcher and patient, but investors. Successful clinical translation of technologies requires a...
View ArticleMonday morning musings: stem cell stocks, ISSCR, grants, CRISPR, New Book, &...
What’s on your mind on this Monday morning? Are you caffeinated enough yet? Depending on where you live it may even be time for dinner, bed, or already early Tuesday. Here’s some musings… To get safe...
View ArticleTale of 7 stem cell stock woes: how low can they go?
To get from point A of a stem cell discovery to point B of a patient actually receiving a treatment based on that discovery is a long and non-linear road. Stem cell biotech companies including publicly...
View ArticleCan StemCells Inc. Cheat Death?
California stem cell biotech, StemCells, Inc. ($STEM), has really struggled for years and its stock is now flatlining raising the question: can it cheat death? Will 2016 be the year that STEM turns...
View ArticleEnd of line for StemCells Inc., pioneering & controversial stem cell biotech
A sad, but not surprising day for the stem cell field as the biotech StemCells, Inc. announced that it is winding down its operations after terminating its spinal cord injury trial called the Pathway...
View Article
